Research Focus

Former Employee. Molecular Pharmacology Program; Non-Stipend SKI

Recent additions – View all

1. La cyclooxygenase-2: Nouvelle cible dans le traitment des cancers epitheliaux- Les inhibiteurs des cyclooxygenases

   Journal Article

   Eschwege, P.; de Ledinghen, V.; Camilli, T.; Kulkarni, S.; Dalbagni, G.; Droupy, S.; Jardin, A.; Benoit, G.; Weksler, B. B.
   Presse Medicale (2001)

   Fulltext@MSK | Save
2. La cyclooxygenase-2: Nouvelle cible dans le traitement des cancers epitheliaux - Les cyclooxygenases

   Journal Article

   Eschwege, P.; de Ledinghen, V.; Camilli, T.; Kulkarni, S.; Dalbagni, G.; Droupy, S.; Jardin, A.; Benoit, G.; Weksler, B. B.
   Presse Medicale (2001)

   Fulltext@MSK | Save
3. Cyclooxygenase-2: A new target for epithelial cancer treatments - Arachidonic acid and prostaglandins, inflammation and oncology

   Journal Article

   Eschwege, P.; de Ledinghen, V.; Camilli, T.; Kulkarni, S.; Dalbagni, G.; Droupy, S.; Jardin, A.; Benoit, G.; Weksler, B. B.
   Presse Medicale (2001)

   Fulltext@MSK | Save